 Your new post is loading...
Your new post is loading...
|
Scooped by
Gilbert C FAURE
July 18, 2012 10:48 AM
|
Johns Hopkins tissue engineers have used tiny, artificial fiber scaffolds thousands of times smaller than a human hair to help coax stem cells into developing into cartilage, the shock-absorbing lining of elbows and knees that ...
|
Scooped by
Marcelo de Carvalho Bittencourt
July 18, 2012 10:28 AM
|
OMICS : This is the updated version of OMICS Blog which provide you detail description about the latest Journals | Conferences.
|
|
Scooped by
Gilbert C FAURE
July 18, 2012 9:41 AM
|
NeoStem's Subsidiary, Progenitor Cell Therapy, and SOTIO Enter Into a Phase 3 Manufacturing Services Agreement. ALLENDALE, N.J. and WILMINGTON, Del., July 16, 2012 (GLOBE NEWSWIRE) — NeoStem, Inc. (NYSE MKT:NBS) and its ...
|
|
Scooped by
Gilbert C FAURE
July 17, 2012 1:12 PM
|
Since the successful introduction of the first monoclonal antibody...
|
|
Scooped by
Gilbert C FAURE
July 17, 2012 9:55 AM
|
Emory Vaccine Centers gets $7 million boost for HIV fightThe GA VoiceThe Centers for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID) will be led by the Scripps Research Institute and Duke University but doctors and scientists from...
|
|
Scooped by
Gilbert C FAURE
July 17, 2012 9:53 AM
|
NEWARK, NJ and SEATTLE, WA -- (Marketwire) -- 07/11/12 -- Actinium Pharmaceuticals, Inc. (Actinium Pharmaceuticals, Inc.
|
|
Rescooped by
Gilbert C FAURE
from Immunology
July 16, 2012 8:04 AM
|
Tokyo-based Chugai Pharmaceutical Co., Ltd. has officially opened a new laboratory in Singapore that will conduct research on new antibody drugs.
|
|
Scooped by
Gilbert C FAURE
July 16, 2012 6:50 AM
|
In addition to activation of NK-surface stimulatory receptors, therapeutic monoclonal antibodies such as the anti-KIR monoclonal antibody blocking inhibitory signaling in NK cells have been tested in clinical trials on acute myeloid leukemia and...
|
|
Scooped by
Gilbert C FAURE
July 16, 2012 6:41 AM
|
These include non-specific stimulators, cytokines, monoclonal antibodies, radiolabelled antibodies, immunotoxins, and cell-based therapy (reviewed in [3]). Further ..... Committee for Tumor Immunology and Bio-therapy (TIBT) ...
|
|
Scooped by
Gilbert C FAURE
July 15, 2012 1:45 PM
|
RT @AllergyNet: Readable immunology, with memorable metaphors MT @JuanCIvancevich Chronic T-cell exhaustion. Full text.
|
|
Scooped by
Gilbert C FAURE
July 14, 2012 3:41 AM
|
Immunology: Vaccine Hope for Virile VirusScience Daily (press release)Exploiting the early immune response in Chikungunya fever promises to provide protection.
|
|
Scooped by
Gilbert C FAURE
July 14, 2012 3:38 AM
|
NIHNews: NIH Awards Funding for New Centers for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID) http://t.co/OgbkHCMs...
|
|
|
Scooped by
Marcelo de Carvalho Bittencourt
July 18, 2012 10:31 AM
|
|
|
Scooped by
Gilbert C FAURE
July 18, 2012 9:44 AM
|
Elotuzumab, CS1 Directed Antibody Therapy For Multiple Myeloma: Clinical Trial Results (#clinicaltrials Elotuzumab, CS1 Directed Antibody Therapy For Multiple Myeloma: Clinical Trial Results: Monoclon...)...
|
|
Scooped by
Gilbert C FAURE
July 18, 2012 9:40 AM
|
Cytomedix, Inc. (CMXI) (the “Company”), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies, announces the initiation of a Phase I clinical study with ...
|
|
Scooped by
Gilbert C FAURE
July 17, 2012 9:57 AM
|
Genmab has agreed to collaborate with Janssen Biotech to create and develop antibodies using its DuoBody technology platform and will receive an upfront payment of $3.5 million.
|
|
Scooped by
Gilbert C FAURE
July 17, 2012 9:55 AM
|
ScienceAlertScientists from Singapore Immunological Network Discover Dendritic Cells Key ...SYS-CON Media (press release)Singapore, July 16, 2012 - (ACN Newswire) - Scientists at A*STAR's Singapore Immunology Network (SIgN), in collaboration with ...
|
|
Scooped by
Gilbert C FAURE
July 17, 2012 9:53 AM
|
PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
|
|
Scooped by
Gilbert C FAURE
July 16, 2012 7:48 AM
|
One of the most promising new approaches in modern cancer treatment is immunotherapy or biotherapy, the development of methods to augment and enhance the body's natural tendency to defend itself against malignant ...
|
|
Scooped by
Gilbert C FAURE
July 16, 2012 6:49 AM
|
The usefulness of interferon-gamma (IFN-γ) release assays for tuberculosis screening before tumor necrosis factor-alpha (TNF-α) antagonists and for monitoring during treatment is a contraversial issue.
|
|
Scooped by
Gilbert C FAURE
July 15, 2012 1:46 PM
|
Actinium Pharma gets rights to develop & commercialize BC8 monoclonal antibody from FHCRC (Actinium Pharma gets rights to develop & commercialize BC8 monoclonal antibody from FHCRC http://t.co/7ZIExyFe...)...
|
|
Scooped by
Gilbert C FAURE
July 14, 2012 3:41 AM
|
Immunovaccine's DPX-Survivac Featured in Presentation at Federation of ...MarketWatch (press release)Immunovaccine's DPX-Survivac Featured in Presentation at Federation of Clinical Immunology Societies Conference (FOCIS 2012).
|
|
Scooped by
Gilbert C FAURE
July 14, 2012 3:39 AM
|
Gastroenterology Medical Article: Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease (Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two ...
|
|
Scooped by
Gilbert C FAURE
July 14, 2012 3:36 AM
|
Federal authorities have given the go-ahead to human trials that will use a new stem cell treatment to repair heart attack damage.
|
Scoop.it!
